CAS 2220998-55-8

DTR-I

Produto Controlado

CAS: 2220998-55-8

Applications DTR-I is an intermediate in the synthesis of Tetrabenazine-d6 (T284002), which is a labeled Tetrabenazine. Dopamine depleting agent. An antidyskinetic; antipsychotic.
References Schwartz, et al.: Biochem. Pharmacol., 15, 645 (1966), Janovic, J., et al.: Ann. Neurol., 11, 41 (1982), Janovic, J., et al.: Neurology, 38, 391 (1988),

Fórmula: C₁₇H₂₃NO₃

Cor e Forma: Neat

Peso molecular: 289.369

Ref: TR-D222100

DTR-I

CAS: 2220998-55-8

DTR-I is an analog of ghrelin, a protein hormone that regulates appetite and energy balance. It is a potent inhibitor of kinases, which are enzymes that play a crucial role in cancer cell growth and survival. DTR-I has been shown to induce apoptosis, or programmed cell death, in various types of cancer cells. This anticancer effect is thought to be due to its ability to inhibit the activity of protein kinases that are overexpressed in human tumors. In addition, DTR-I has been found in urine samples from Chinese cancer patients, indicating its potential as a diagnostic marker for certain types of cancer. The development of DTR-I as a novel anticancer agent holds promise for the treatment of various types of cancer in the future.

Fórmula: C₁₇H₂₃NO₃

Pureza: Min. 95%

Peso molecular: 289.4 g/mol

Ref: 3D-VND99855